Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Carboplatin products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A platinum-based chemotherapy used to treat several types of cancer.
Products affected
1 / 3
In shortage since
Oct 21, 2020
Reports on file
20
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · since Oct 21, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · since Mar 3, 2021, no end estimate · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02320371 · ended Jul 9, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02320371 · ended Feb 26, 2026 · Requirements related to complying with good manufacturing practices.
Avoided
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Aug 9, 2024 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Oct 4, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended May 16, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Nov 15, 2022 · Delay in shipping of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Nov 1, 2021 · Delay in shipping of the drug.
Showing 12 of 20 reports. All reports are on file with Health Canada.
What's happening
Carboplatin is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Carboplatin is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XA).
Recent changes
Jul 10, 2026
Shortage resolved
Common questions
What is Carboplatin used for?
A platinum-based chemotherapy used to treat several types of cancer.
When will Carboplatin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Carboplatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.